Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group

F. Theis; A. Corbacioglu; V. I. Gaidzik; P. Paschka; D. Weber; L. Bullinger; M. Heuser; A. Ganser; F. Thol; B. Schlegelberger; G. Göhring; C. H. Köhne; U. Germing; P. Brossart; H. A. Horst; D. Haase; K. Götze; M. Ringhoffer; W. Fiedler; D. Nachbaur; T. Kindler; G. Held; M. Lübbert; M. Wattad; H. R. Salih; J. Krauter; H. Döhner; R. F. Schlenk; K. Döhner

doi:10.1038/leu.2016.185

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group

F. Theis, A. Corbacioglu, V. I. Gaidzik, P. Paschka, D. Weber, L. Bullinger, M. Heuser, A. Ganser, F. Thol, B. Schlegelberger, G. Göhring, C. H. Köhne, U. Germing, P. Brossart, H. A. Horst, D. Haase, K. Götze, M. Ringhoffer, W. Fiedler, D. NachbaurT. Kindler, G. Held, M. Lübbert, M. Wattad, H. R. Salih, J. Krauter, H. Döhner, R. F. Schlenk, K. Döhner

Research output: Contribution to journal › Letter › peer-review

37 Scopus citations

Original language	English
Pages (from-to)	2248-2250
Number of pages	3
Journal	Leukemia
Volume	30
Issue number	11
DOIs	https://doi.org/10.1038/leu.2016.185
State	Published - 1 Nov 2016
Externally published	Yes

Access to Document

10.1038/leu.2016.185

Cite this

Theis, F., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Weber, D., Bullinger, L., Heuser, M., Ganser, A., Thol, F., Schlegelberger, B., Göhring, G., Köhne, C. H., Germing, U., Brossart, P., Horst, H. A., Haase, D., Götze, K., Ringhoffer, M., Fiedler, W., ... Döhner, K. (2016). Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group. Leukemia, 30(11), 2248-2250. https://doi.org/10.1038/leu.2016.185

@article{9fd834a4c8e14fbd9e28050cf5ecdb0d,

title = "Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group",

author = "F. Theis and A. Corbacioglu and Gaidzik, {V. I.} and P. Paschka and D. Weber and L. Bullinger and M. Heuser and A. Ganser and F. Thol and B. Schlegelberger and G. G{\"o}hring and K{\"o}hne, {C. H.} and U. Germing and P. Brossart and Horst, {H. A.} and D. Haase and K. G{\"o}tze and M. Ringhoffer and W. Fiedler and D. Nachbaur and T. Kindler and G. Held and M. L{\"u}bbert and M. Wattad and Salih, {H. R.} and J. Krauter and H. D{\"o}hner and Schlenk, {R. F.} and K. D{\"o}hner",

year = "2016",

month = nov,

day = "1",

doi = "10.1038/leu.2016.185",

language = "English",

volume = "30",

pages = "2248--2250",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "11",

}

Theis, F, Corbacioglu, A, Gaidzik, VI, Paschka, P, Weber, D, Bullinger, L, Heuser, M, Ganser, A, Thol, F, Schlegelberger, B, Göhring, G, Köhne, CH, Germing, U, Brossart, P, Horst, HA, Haase, D, Götze, K, Ringhoffer, M, Fiedler, W, Nachbaur, D, Kindler, T, Held, G, Lübbert, M, Wattad, M, Salih, HR, Krauter, J, Döhner, H, Schlenk, RF & Döhner, K 2016, 'Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group', Leukemia, vol. 30, no. 11, pp. 2248-2250. https://doi.org/10.1038/leu.2016.185

TY - JOUR

T1 - Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations

T2 - A study of the AML study group

AU - Theis, F.

AU - Corbacioglu, A.

AU - Gaidzik, V. I.

AU - Paschka, P.

AU - Weber, D.

AU - Bullinger, L.

AU - Heuser, M.

AU - Ganser, A.

AU - Thol, F.

AU - Schlegelberger, B.

AU - Göhring, G.

AU - Köhne, C. H.

AU - Germing, U.

AU - Brossart, P.

AU - Horst, H. A.

AU - Haase, D.

AU - Götze, K.

AU - Ringhoffer, M.

AU - Fiedler, W.

AU - Nachbaur, D.

AU - Kindler, T.

AU - Held, G.

AU - Lübbert, M.

AU - Wattad, M.

AU - Salih, H. R.

AU - Krauter, J.

AU - Döhner, H.

AU - Schlenk, R. F.

AU - Döhner, K.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=84978712088&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.185

DO - 10.1038/leu.2016.185

M3 - Letter

C2 - 27375010

AN - SCOPUS:84978712088

SN - 0887-6924

VL - 30

SP - 2248

EP - 2250

JO - Leukemia

JF - Leukemia

IS - 11

ER -

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group

Access to Document

Other files and links

Cite this